VYNE - VYNE Therapeutics GAAP EPS of -$2.60 March, 09 2023 05:02 PM VYNE Therapeutics Inc Com 2023-03-09 17:02:29 ET VYNE Therapeutics press release ( NASDAQ: VYNE ): Q4 GAAP EPS of -$2.60. As of December 31, 2022, VYNE had cash and cash equivalents, and restricted cash of $31.0 million. For further details see: VYNE Therapeutics GAAP EPS of -$2.60